460 related articles for article (PubMed ID: 18946352)
1. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
2. Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo.
Cai S; Choi JY; Borges TJ; Zhang H; Miao J; Ichimura T; Li X; Xu S; Chu P; Eskandari SK; Allos H; Alhaddad JB; Muhsin SA; Yatim K; Riella LV; Sage PT; Chandraker AK; Azzi JR
Sci Rep; 2020 Aug; 10(1):14249. PubMed ID: 32859934
[TBL] [Abstract][Full Text] [Related]
3. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
4. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function.
Liang S; Zhang W; Horuzsko A
Eur J Immunol; 2006 Sep; 36(9):2457-71. PubMed ID: 16897816
[TBL] [Abstract][Full Text] [Related]
5. Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.
Sido JM; Nagarkatti PS; Nagarkatti M
J Leukoc Biol; 2015 Sep; 98(3):435-47. PubMed ID: 26034207
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide.
Liao J; Wang X; Bi Y; Shen B; Shao K; Yang H; Lu Y; Zhang Z; Chen X; Liu H; Wang J; Chu Y; Xue L; Wang X; Liu G
J Leukoc Biol; 2014 Nov; 96(5):675-84. PubMed ID: 24948701
[TBL] [Abstract][Full Text] [Related]
7. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism.
Zhao Y; Shen XF; Cao K; Ding J; Kang X; Guan WX; Ding YT; Liu BR; Du JF
Front Immunol; 2018; 9():282. PubMed ID: 29497426
[TBL] [Abstract][Full Text] [Related]
9. Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model.
Gong W; Ge F; Liu D; Wu Y; Liu F; Kim BS; Huang T; Koulmanda M; Robson SC; Strom TB
Clin Immunol; 2014 Jul; 153(1):8-16. PubMed ID: 24691417
[TBL] [Abstract][Full Text] [Related]
10. Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway.
Wu T; Sun C; Chen Z; Zhen Y; Peng J; Qi Z; Yang X; Zhao Y
J Immunol; 2012 Nov; 189(10):4989-5000. PubMed ID: 23045614
[TBL] [Abstract][Full Text] [Related]
11. The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation.
Wang X; Bi Y; Xue L; Liao J; Chen X; Lu Y; Zhang Z; Wang J; Liu H; Yang H; Liu G
Mol Cell Biol; 2015 Feb; 35(3):598-609. PubMed ID: 25452304
[TBL] [Abstract][Full Text] [Related]
12. The roles of sepsis-induced myeloid derived suppressor cells in mice corneal, skin and combined transplantation.
He Y; Bei J; Zeng H; Pan Z
Transpl Immunol; 2016 Feb; 34():8-13. PubMed ID: 26733333
[TBL] [Abstract][Full Text] [Related]
13. Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance.
Wu J; Zhang W; Hernandez-Lopez P; Fabelo E; Parikh M; Mulloy LL; Horuzsko A
Hum Immunol; 2009 Dec; 70(12):988-94. PubMed ID: 19664670
[TBL] [Abstract][Full Text] [Related]
14. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
[TBL] [Abstract][Full Text] [Related]
16. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
[TBL] [Abstract][Full Text] [Related]
17. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor.
Liang S; Baibakov B; Horuzsko A
Eur J Immunol; 2002 Sep; 32(9):2418-26. PubMed ID: 12207326
[TBL] [Abstract][Full Text] [Related]
18. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.
Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N
J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088
[TBL] [Abstract][Full Text] [Related]
19. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
20. HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4.
Köstlin N; Ostermeir AL; Spring B; Schwarz J; Marmé A; Walter CB; Poets CF; Gille C
Eur J Immunol; 2017 Feb; 47(2):374-384. PubMed ID: 27859042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
